SeaSpine earns FDA clearance for new OsteoBallast product: 5 things to know

Biologics

The FDA cleared SeaSpine's OsteoBallast Demineralized Bone Matrix in Resorbable Mesh.

Here are five things to know:

 

1. The new product features a resorbable mesh made of demineralized bone matrix.

 


2. The OsteoBallast Demineralized Bone Matrix is intended to simplify graft placement as well as reduce graft movement.

 

3. SeaSpine designed the product to help with graft delivery during posterior spine surgery.

 

4. Surgeons will likely find the product especially useful for minimally invasive spine surgeries.

 

5. SeaSpine reported it will initiate a limited release of the new product in 2017 with a full launch by mid-2018.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers